1. Home
  2. ACIW vs ADMA Comparison

ACIW vs ADMA Comparison

Compare ACIW & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACI Worldwide Inc.

ACIW

ACI Worldwide Inc.

HOLD

Current Price

$49.12

Market Cap

4.8B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.70

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIW
ADMA
Founded
1975
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.1B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ACIW
ADMA
Price
$49.12
$19.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$60.00
$28.50
AVG Volume (30 Days)
777.7K
3.0M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
16.89
205.35
EPS
2.47
0.86
Revenue
$1,731,220,000.00
$488,559,000.00
Revenue This Year
$11.40
$22.19
Revenue Next Year
$1.46
$24.33
P/E Ratio
$19.46
$22.87
Revenue Growth
7.01
27.63
52 Week Low
$40.45
$13.50
52 Week High
$58.14
$25.67

Technical Indicators

Market Signals
Indicator
ACIW
ADMA
Relative Strength Index (RSI) 61.56 61.93
Support Level $47.92 $18.33
Resistance Level $48.87 $20.46
Average True Range (ATR) 1.12 0.70
MACD 0.37 -0.17
Stochastic Oscillator 98.70 64.38

Price Performance

Historical Comparison
ACIW
ADMA

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: